In this context, TCM has emerged as a promising alternative, leveraging its multi-target regulatory networks (e.g., mTOR pathway modulation, oxidative stress mitigation, and autophagic flux restoration) to address systemic imbalances in DKD progression. The gene discussed is MTOR; the disease is diabetic kidney disease.